[1] |
李明明,王春红,吉宏明.胶质母细胞瘤侵袭性的相关研究进展[J].临床神经外科杂志, 2018, 15(3): 238-240.
|
[2] |
Renovanz M, Maurer D, Lahr H, et al. Supportive care needs in glioma patients and their caregivers in clinical practice: results of a multicenter cross-sectional study[J]. Front Neurol, 2018, 9: 763.
|
[3] |
Lee I. Advances in surgical approaches in glioblastoma (GBM)[J]. Chin Clin Oncol, 2017, 6(4): 42.
|
[4] |
山常国,赖名耀,洪伟平,等.长周期替莫唑胺治疗胶质母细胞瘤[J].实用医学杂志, 2017, 33(16): 2743-2746.
|
[5] |
Ma X, Wang J, Wang J, et al. The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis[J]. Oncotarget, 2017, 8(3): 4062-4078.
|
[6] |
常彬,卢立霞,涂小予,等.子宫内膜间质肉瘤的病理形态学观察及JAZF1-SUZ12和YWHAE-FAM22融合基因检测[J].中华病理学杂志, 2016, 45(5): 308-313.
|
[7] |
Stevens VL, Ahn J, Sun J, et al. HNF1B and JAZF1 genes, diabetes, and prostate cancer risk[J]. Prostate, 2010, 70(6): 601-607.
|
[8] |
欧阳一彬,莫业和,何青龙,等.影响脑胶质瘤患者生存和预后的相关因素分析[J].河北医药, 2018, 40(10): 1524-1526, 1530.
|
[9] |
张建平,冯海明,秦振伟,等. PD-1/PD-L1在脑胶质瘤中的表达及其预后相关性的Meta分析[J].中华神经外科杂志, 2018, 34(4): 417-422.
|
[10] |
刘桂云,江蓉,徐晨阳,等.高级别脑胶质瘤综合治疗后生存分析[J].中南大学学报(医学版), 2018, 43(4): 388-393.
|
[11] |
刘成业,李钢.基因治疗神经胶质瘤的现状和展望[J].实用临床医药杂志, 2016, 20(13): 229-232.
|
[12] |
余双全,姚瑜,周良辅.胶质瘤免疫逃逸及对策研究的现状与展望[J].中华医学杂志, 2018, 98(5): 321-323.
|
[13] |
Johansson A, Marroni F, Hayward C, et al. Common variants in the JAZF1 gene associated with height identified by linkage and genome-wide association analysis[J]. Hum Mol Genet, 2009, 18(2): 373-380.
|
[14] |
代从新,王裕,马文斌.脑胶质瘤动物模型的研究进展[J].中华医学杂志, 2018, 98(25): 2052-2054.
|